Safety of BLP25 liposome vaccine (L-BLP25) in Japanese patients with unresectable stage III NSCLC after primary chemoradiotherapy: preliminary results from a Phase I/II study.

Source:http://linkedlifedata.com/resource/pubmed/id/21393255

Download in:

View as

General Info

PMID
21393255